2004Chinese Remedies & ClinicsRequires access

Clinical observation on scheme optimization of mobilization effects of granulocyte colony-stimulating factor on stem cells

Zhao Hong-ya

Open publisher page 1 citations

Abstract

Objective Observe the mobilization effects of granulocyte colony-stimulating factor (G-CSF) on stem cells in patients with acute myocardial infarction (AMI), so as to find out an optimized scheme. Methods Forteen patients with AMI were randomly allocated to receive G-CSF to mobilize the stem cell,with either 300 μg/d (group A) or 600 μg/d (group B). The patients received G-CSF by hypodermic injection,and the duration was 5 days. In the process of the mobilization of the circulating blood stem cell, the white blood cell (WBC) and CD34+ cell counts in the circulating blood had been observed. Results Prior to applying G-CSF and the 2nd, 3rd, 4th, 5th, 6th, 7th, and 8th days after applying G-CSF, the counts of WBC had no significant difference between this two groups; but the 3rd, 5th, 6th, and 7th days after applying G-CSF, the counts of CD34+ cell had significant difference between this two groups (P=0.007, 0.019, 0.011, 0.005), CD34+ cell count in the circulating blood of group B was higher than that of groupA; the WBC and CD34+ counts peaked on the 5th day after applying G-CSF; CD34+ cell count in the circulating blood was positively related with the WBC count in the circulating blood (r=-0.659), was negatively related with body weight of patients (r=-0.356), not related with sex, age, or the onset time of AMI. Conclusion In patients with AMI, mobilization effect of G-CSF 600 μg/d on stem cells is better than that of G-CSF 300 μg/d.

About this research paper

What this paper is about

Objective Observe the mobilization effects of granulocyte colony-stimulating factor (G-CSF) on stem cells in patients with acute myocardial infarction (AMI), so as to find out an optimized scheme. Methods Forteen patients with AMI were randomly allocated to receive G-CSF to mobilize the stem cell,with either 300 μg/d (group A) or 600 μg/d (group B). The patients received G-CSF by hypodermic injection,and the duration was 5 days. In the process of the mobilization of the circulating blood stem cell, the white blood cell (WBC) and CD34+ cell counts in the circulating blood had been observed. Results Prior to applying G-CSF and the 2nd, 3rd, 4th, 5th, 6th, 7th, and 8th days after applying G-CSF, the counts of WBC had no significant difference between this two groups; but the 3rd, 5th, 6th, and 7th days after applying G-CSF, the counts of CD34+ cell had significant difference between this two groups (P=0.007, 0.019, 0.011, 0.005), CD34+ cell count in the circulating blood of group B was higher than that of groupA; the WBC and CD34+ counts peaked on the 5th day after applying G-CSF; CD34+ cell count in the circulating blood was positively related with the WBC count in the circulating blood (r=-0.659), was negatively related with body weight of patients (r=-0.356), not related with sex, age, or the onset time of AMI. Conclusion In patients with AMI, mobilization effect of G-CSF 600 μg/d on stem cells is better than that of G-CSF 300 μg/d.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective Observe the mobilization effects of granulocyte colony-stimulating factor (G-CSF) on stem cells in patients with acute myocardial infarction (AMI), so as to find out an optimized scheme. Methods Forteen patients with AMI were randomly allocated to receive G-CSF to mobilize the stem cell,with either 300 μg/d (group A) or 600 μg/d (group B). The patients received G-CSF by hypodermic injection,and the duration was 5 days. In the process of the mobilization of the circulating blood stem cell, the white blood cell (WBC) and CD34+ cell counts in the circulating blood had been observed. Results Prior to applying G-CSF and the 2nd, 3rd, 4th, 5th, 6th, 7th, and 8th days after applying G-CSF, the counts of WBC had no significant difference between this two groups; but the 3rd, 5th, 6th, and 7th days after applying G-CSF, the counts of CD34+ cell had significant difference between this two groups (P=0.007, 0.019, 0.011, 0.005), CD34+ cell count in the circulating blood of group B was higher than that of groupA; the WBC and CD34+ counts peaked on the 5th day after applying G-CSF; CD34+ cell count in the circulating blood was positively related with the WBC count in the circulating blood (r=-0.659), was negatively related with body weight of patients (r=-0.356), not related with sex, age, or the onset time of AMI. Conclusion In patients with AMI, mobilization effect of G-CSF 600 μg/d on stem cells is better than that of G-CSF 300 μg/d.

Key concepts: Granulocyte colony-stimulating factor, Medicine, White blood cell, CD34, Stem cell, Internal medicine, Granulocyte, Mobilization

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation on scheme optimization of mobilization effects of granulocyte colony-stimulating factor on stem cells — Research Paper | ScholarLens